TY  - JOUR

T1  - Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom.

JO  - Rheumatology (Oxford)

PY  - 2007/08/01

AU  - Botteman MF

AU  - Hay JW

AU  - Luo MP

AU  - Curry AS

AU  - Wong RL

AU  - van Hout BA

ED  - 

DO  - DOI: 10.1093/rheumatology/kem031

VL  - 46

IS  - 8

SP  - 1320

EP  - 1328

Y2  - 2024/12/22

ER  -